Drug sensitivity of Leishmania species: Some unresolved problems

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 96, Issue SUPPL. 1, 2002, Pages

  Croft, Simon L ^a   Yardley, Vanessa ^a   Kendrick, Howard ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Allopurinol; Aminosidine; Azoles; Drug screening; Drug sensitivity; Leishmania spp; Leishmaniasis; Meglumine antimoniate; Paromomycin; Sodium stibogluconate

Indexed keywords

2 (2,4 DIFLUOROPHENYL) 1 [3 [2 [4 (2,2,3,3 TETRAFLUOROPROPOXY)PHENYL]VINYL] 1,2,4 TRIAZOL 1 YL] 3 (1,2,4 TRIAZOL 1 YL) 2 PROPANOL; ALLOPURINOL; ALLOPURINOL RIBOSIDE; ALLYLAMINE; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; ANTILEISHMANIAL AGENT; IMIDAZOLE; ITRACONAZOLE; KETOCONAZOLE; MEGLUMINE ANTIMONATE; MOLECULAR MARKER; NEW DRUG; PAROMOMYCIN; PLACEBO; PYRAZOLOPYRIMIDINE DERIVATIVE; STIBOGLUCONATE SODIUM; TERBINAFINE;

ARTICLE; CONTROLLED STUDY; DRUG IDENTIFICATION; DRUG SENSITIVITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LEISHMANIA; LEISHMANIASIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; REPORTER GENE; SPECIES DIFFERENCE; SPECIES IDENTIFICATION;

EID: 0036335635     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(02)90063-5     Document Type: Article

References (21)

1. Persistence of virulent Leishmania major in murine cutaneous leishmaniasis: A possible hazard for the host
2. Pharmacokinetics of antimony in patients treated with sodium stibogluconate for cutaneous leishmaniasis
3. The in vitro susceptibility of macrophages infected with amastigotes of Leishmania spp. to pentavalent antimonial drugs and other compounds with special relevance to cutaneous isolates
4. Comparative effects of 4-aminopyrazolopyrimidine, its 2′-deoxyriboside derivative, and allopurinol on in vitro growth of American Leishmania species
5. Effects of antimycotic azoles on growth and sterol biosynthesis of Leishmania promastigotes
6. In vitro susceptibility of antimony-resistant Leishmania to alternative drugs
7. Efficacy and safety of liposomal amphotericin B (AmBisome™) for visceral leishmaniasis in endemic developing countries
8. Efficient technique for screening drugs against Trypanosoma cruzi using parasites expressing β-galactosidase
9. Detection of live Trypanosoma cruzi in tissues of infected mice by using histochemical stain for β-galactosidase
10. In vitro screens in the experimental chemotherapy of leishmaniasis and trypanosomiasis
11. Chemotherapy of human leishmaniasis and trypanosomiasis
12. Drug resistance in leishmaniasis: Its implication in systemic chemotherapy of cutaneous and mucocutaneous disease
13. Dissecting the biology of a pathogen during infection
14. A simple method for quantifying Leishmania in tissues of infected mice
15. Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani
16. Placebo-controlled clinical trial of sodium stibogluconate (Pentostam™) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala
17. Anti-leishmanial effect of allopurinol ribonucleoside and the related compounds, allopurinol, thiopurinol, thiopurinol riboside, and of formycin B, sinefungin and the lepidine WR6026
18. The sensitivity of Leishmania species to aminosidine
19. Allopurinol ribonucleoside as an antileishmanial agent
20. Naturally azole-resistant Leishmania braziliensis promastigotes are rendered susceptible in the presence of terbinafine: Comparative study with azole-susceptible Leishmania mexicana promastigotes
21. A new standard for the assessment of disease progression in murine cutaneous leishmaniasis